𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Genetic polymorphism of N-acetyltransferase 2 in the susceptibility to laryngeal squamous cell carcinoma

✍ Scribed by Murat Ünal; Lülüfer Tamer; Yücel Akbaş; Yavuz Selim Pata; Yusuf Vayisoǧlu; Ulaş Deǧirmenci; Handan Çamdeviren


Publisher
John Wiley and Sons
Year
2005
Tongue
English
Weight
78 KB
Volume
27
Category
Article
ISSN
1043-3074

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

Background.

The purpose of this study was to investigate whether polymorphism of N‐acetyltransferase 2 (NAT2) genotypes are associated with the risk of laryngeal squamous cell carcinoma (SCC).

Methods.

The study group consisted of 45 white patients with laryngeal SCC (42 men, with a mean age of 54 years [range, 37–70 years] and three women, with a mean age of 47 years [range, 32–55 years]) and 104 control subjects (68 men and 36 women; mean age, 50 years; range, 28–73 years). All of the patients were primarily treated with surgical intervention. Blood samples (5 mL) were obtained before surgery or from the patients under follow‐up to 5 years after surgery (mean follow‐up, 27 months; range, 6–48 months). DNA was extracted from the lymphocytes by high pure template preparation kit. NAT2*5A, NAT2*6A, NAT2*7A/B, and NAT2*14A were detected by use of LightCycler‐NAT2 mutation detection kit by real‐time polymerase chain reaction with Light Cycler instruments. The association between NAT2 polymorphisms and laryngeal SCC was prospectively modeled through multivariate logistic regression analysis.

Results.

We found that the risk of laryngeal SCC was 7.3‐fold higher in individuals with NAT2*5 mutant allele, 3.8‐fold higher in subjects with NAT2*6 heterozygote allele, and 38.3‐fold higher in NAT2*6 mutant allele. We also found that individuals with NAT2*7 heterozygote allele had a 0.2‐fold less risk for the development of laryngeal SCC (p = .018).

Conclusion.

In this population, patients with NAT2*5 mutant and *6 heterozygous and mutant genotypes had a significantly higher risk for development of laryngeal SCC. © 2005 Wiley Periodicals, Inc. Head Neck 27: XXX–XXX, 2005


📜 SIMILAR VOLUMES


Association between genetic polymorphism
✍ Shunji Morita; Masahiko Yano; Toshimasa Tsujinaka; Atsuhiro Ogawa; Masaaki Tanig 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 French ⚖ 75 KB 👁 2 views

We examined the effect of genetic polymorphisms of phase-II enzymes, glutathione S-transferase P1 (GSTP1) and N-acetyltrans-ferase2 (NAT2) on susceptibility to esophageal squamous-cell carcinoma. To determine the genotypes of the 2 polymorphisms, PCR-based analysis was performed on samples from 66 J

Genetic polymorphisms of drug-metabolizi
✍ Shunji Morita; Masahiko Yano; Toshimasa Tsujinaka; Yosuke Akiyama; Masaaki Tanig 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 French ⚖ 51 KB 👁 2 views

We have investigated the association between the polymorphisms of drug-metabolizing enzymes and susceptibility to head-and-neck squamous-cell carcinoma (HNSCC). PCRbased analysis was performed on 145 Japanese patients and 164 healthy Japanese controls to determine genotypes of polymorphisms in CYP1A

Management of the N0 neck in recurrent l
✍ Isaac A. Bohannon; Renee A. Desmond; Lisa Clemons; J. Scott Magnuson; William R. 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 80 KB 👁 1 views

## Abstract ## Objectives/Hypothesis: To evaluate the utility of neck dissections in patients undergoing salvage laryngectomy with a clinically negative neck. ## Study Design: Retrospective cohort study. ## Methods: This retrospective review identified 71 patients with N0 necks who underwent s

Inherited polymorphism in the N-acetyltr
✍ Takahiko Katoh; Robert Boissy; Naoki Nagata; Kyoko Kitagawa; Yusuke Kuroda; Hide 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 French ⚖ 50 KB 👁 1 views

The polymorphic arylamine N-acetyltransferases (NAT1 and NAT2) have been implicated in increased susceptibility to certain malignancies. We analyzed genetic polymorphisms in both the NAT1 and NAT2 genes among 140 gastric adenocarcinoma patients, 103 colorectal adenocarcinoma patients and 122 healthy